Landfar Bio-medicine Co., Ltd (SHE:000504)

China flag China · Delayed Price · Currency is CNY
9.96
+0.47 (4.95%)
Mar 10, 2026, 2:04 PM CST
-8.54%
Market Cap 3.13B
Revenue (ttm) 125.47M
Net Income (ttm) -6.20M
Shares Out 330.02M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,879,826
Average Volume 2,498,449
Open 8.81
Previous Close 9.49
Day's Range 8.81 - 9.96
52-Week Range 5.43 - 12.54
Beta 0.73
RSI 63.14
Earnings Date Apr 29, 2026

About Landfar Bio-medicine

Landfar Bio-medicine Co., Ltd operates as a biomedical technology company. It operates in two segments, Biomedicine, and Energy Saving and Environmental Protection. The Biomedicine segment engages in the provision of stem cell, immune cell storage and technical services, and medical device trade. The Energy Saving and Environmental Protection segment is involved in the external energy management contract energy management business; build-transfer business and sales of related products; and sewage treatment business. The company was founded in 1... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1991
Employees 378
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000504
Full Company Profile

Financial Performance

In 2024, Landfar Bio-medicine's revenue was 134.45 million, a decrease of -1.71% compared to the previous year's 136.79 million. Losses were -19.85 million, -29.56% less than in 2023.

Financial Statements

News

There is no news available yet.